NEW DEVELOPMENTS IN NEUROIMMUNOLOGY
Pathology of myelin oligodendrocyte glycoprotein antibody–associated disease
Graphical Abstract
The difference of pathological mechanisms in myelin oligodendrocyte glycoprotein (MOG) and aquaporin-4 (AQP4) antibody.
CONFLICT OF INTEREST
Dr Tatsuro Misu has received speaker honoraria from Biogen Idec Japan, Mitsubishi Tanabe Pharma Corporation, Asahi Kasei Medical Co., Novartis pharma, Alexion Pharma, and Viela Bio and has received research support from Cosmic Corporation and Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology and the Ministry of Health, Labor and Welfare of Japan.
